DNTH compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

DNTHDianthus Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DNTH

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.7%▲+1.90%×0.20

May 6 '26±7.6%▲+0.20%×0.03

Q1 FY26±11.9%▲+21.52%×1.81

Jan 12 '26±9.0%▲+2.44%×0.27

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedDNTH realized, solidLLY realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

DNTHDianthus Therapeutics, Inc.

83.12▼−3.14%· post 83.12

Mkt cap$4.8BRevenue$1MQ3 FY26Revenue$6MFY24

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

DNTHDianthus Therapeutics, Inc.

LLYELI Lilly & Co

83.12▼−3.14%post 83.12

Price

1,371.32▼−3.29%post 1,363.77

$4.8B

Mkt cap

$1.2T

Q3 FY26$1M

Revenue

$24.4BQ3 FY26

FY24$6M

Revenue

$65.2BFY25

DNTH83.12▼−3.14%vsLLY1,371.32▼−3.29%ClosedNov 5 '26